Pulmonary embolism: complications of therapy.
Glenny
R W
RW
Department of Medicine, Duke University Medical Center, Durham, NC.
D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D014682:Vena Cava, Inferior / Q000601:surgery; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D014859:Warfarin; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator